Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited

Positive

AI Analysis

Summary

Piramal Pharma Limited completed its acquisition of a controlling stake in Yapan Bio Private Limited, a contract development and manufacturing organization specializing in process development and GMP manufacturing services for vaccines and biologics. The acquisition builds on Piramal's existing minority stake in Yapan Bio held since 2021.

Outcome Details

Completed acquisition of controlling stake in Yapan Bio Private Limited

Importance:6/10

Sentiment:

0.60

acquisitioncontrolling stakevaccinesbiologicsmanufacturingprocess development

Read the original article

Published by PR Newswire Biotech on August 18, 2026 7:36 PM

Read Original